Chlamydia trachomatis is an obligate intracellular bacterium that is dependent on its host cell for nucleotides. Chlamydia imports ribonucleotide triphosphates (NTPs) but not deoxyribonucleotide triphosphates (dNTPs) and instead uses ribonucleotide reductase to convert imported ribonucleotides into deoxyribonucleotides for DNA synthesis. The genes encoding ribonucleotide reductase have been recently shown to be negatively controlled by a conserved regulator called NrdR. In this study, we provide direct evidence that Escherichia coli NrdR is a transcriptional repressor and that C. trachomatis CT406 encodes its chlamydial ortholog. We showed that CT406 binds specifically to two NrdR boxes upstream of the nrdAB operon in C. trachomatis. Using an in vitro transcription assay, we confirmed that these NrdR boxes function as an operator since they were necessary and sufficient for CT406-mediated repression. We validated our in vitro findings with reporter studies in E. coli showing that both E. coli NrdR and CT406 repressed transcription from the E. coli nrdH and C. trachomatis nrdAB promoters in vivo. This in vivo repression was reversed by hydroxyurea treatment. Since hydroxyurea inhibits ribonucleotide reductase and reduces intracellular deoxyribonucleotide levels, these results suggest that NrdR activity is modulated by a deoxyribonucleotide corepressor.
Chlamydia trachomatis is a Gram-negative obligate intracellular parasite and a significant human pathogen. It is the causative agent of the most frequently reported bacterial sexually transmitted disease in the United States (5) . C. trachomatis also causes trachoma, the world's most common form of infectious blindness (23) . Within an infected cell, this organism exists as a metabolically active form called the reticulate body (RB), which divides by binary fission. RBs reside at all times within a membrane-bound cytoplasmic inclusion and acquire lipids, proteins, and other nutrients from the host cell (27) . Chlamydia spp. are unusual among bacteria in having a second morphological form called the elementary body (EB), which is specialized for extracellular survival and the ability to infect a new host cell to initiate another round of intracellular infection.
Chlamydia has been so successful in adapting to life inside a eukaryotic cell that it is now completely dependent on its host cell for survival and replication. Over the course of its evolution, Chlamydia has reduced its genome to approximately 1,000 genes (22, 33) , compared to about 5,000 in Escherichia coli (2) , dispensing with many genes whose functions can be replaced by the host cell. For example, C. trachomatis does not encode enzymes involved in the biosynthesis of amino acids such as aspartate and tyrosine and has only a partial biosynthetic pathway for tryptophan (33) . Chlamydiae also depend on the host cell for nucleotides, which are the essential building blocks of RNA and DNA (18) . While C. trachomatis can synthesize CTP, it is auxotrophic for ATP, GTP, and UTP, which it imports from the host cell (39, 40) . Chlamydiae do not import deoxyribonucleotide triphosphates (dNTPs), however, and instead use the enzyme ribonucleotide reductase to convert imported ribonucleotides into deoxyribonucleotides (38) .
Ribonucleotide reductase is conserved from prokaryotes to eukaryotes and is responsible for production of all four dNDPs from their respective NDPs (17) . E. coli expresses three different ribonucleotide reductases from the nrdAB, nrdDG, and nrdHIEF (nrdH) operons (2) . In contrast, all Chlamydia spp. express a single class Ia ribonucleotide reductase encoded by the nrdAB operon (26) . In bacteria, expression of the ribonucleotide reductase genes can be positively or negatively regulated at the transcriptional level. For example, in E. coli, the DNA replication initiation factor DnaA represses nrdAB when bound to ATP (9) . Fis and IciA, on the other hand, are factors that activate nrdAB transcription (12, 14) .
The expression of ribonucleotide reductase genes is also regulated by a transcription factor called NrdR. NrdR was first described in Streptomyces coelicolor (3) , and its cognate operator, the NrdR box, was predicted from a comparative bioinformatics analysis of 63 bacterial genomes (24) . A consensus NrdR box sequence has been proposed (acaCwAtATaTwGt gt), and tandem NrdR boxes have been identified upstream of genes encoding ribonucleotide reductase and factors involved in DNA maintenance and replication (24) . There is genetic evidence in several bacterial species that NrdR negatively regulates nrd transcription in vivo (3, 10, 19, 21, 41) . NrdR has also been shown to bind to NrdR boxes (10, 11, 41) , although it has not been directly shown to repress transcription in vitro. NrdR contains an ATP cone for nucleotide binding and a zinc ribbon for DNA binding (24) , and binding to nucleotides and zinc has been demonstrated (10) . These observations have led to speculation that NrdR may regulate intracellular pools of nucleotides in response to a nucleotide or metal ion, but a cofactor requirement has not been shown.
A putative NrdR ortholog has been identified in all Chlamydia spp. (24) , but there have been no functional studies to validate these predictions. In C. trachomatis, the candidate NrdR ortholog is encoded by CT406, which has 45% amino acid similarity to E. coli NrdR (E. D. R. Case and M. Tan, unpublished observation). In addition, tandem NrdR boxes have been predicted upstream of the nrdAB operon, which is the only predicted target in Chlamydia spp. (24) . To examine whether CT406 is the chlamydial ortholog of NrdR, we performed functional studies to determine if CT406 is able to bind the predicted NrdR boxes and repress transcription of nrdAB and if repression is regulated by intracellular nucleotide levels.
MATERIALS AND METHODS
Extraction of chlamydial total RNA. To prepare chlamydial RNA, eight T150 flasks of subconfluent mouse L929 fibroblast monolayers were infected with C. trachomatis serovar D strain UW-3/Cx at a multiplicity of infection (MOI) of 20.
At 24 h postinfection, the chlamydial RBs were harvested as previously described (35) . Total RNA was extracted using RNA STAT-60 according to the manufacturer's instructions. The purified RNA was treated with RQ1 DNase (Roche) to remove any contaminating genomic DNA.
Mapping of nrdAB transcription start site by 5 RACE. Ten micrograms of chlamydial total RNA was used to synthesize nrdA cDNA by using 2 pmol of the gene-specific primer T653 and AMV reverse transcriptase (Promega). The sequences of all primers and DNA oligonucleotides used in this study are presented in Table 1 . Following reverse transcription, the RNA was hydrolyzed and the cDNA was purified using the QIAquick PCR purification kit (Qiagen) according to the manufacturer's instructions. The 5Ј RACE protocol was adapted from the 5Ј RACE system for rapid amplification of cDNA ends, version 2.0 (Invitrogen). Briefly, a poly(dC) tail was added to the 5Ј end of the purified cDNA by 1 U terminal deoxynucleotidyl transferase (Promega). Five microliters of tailed cDNA was amplified using primers T602 and T694. The resulting PCR product was digested with EcoRI (Promega) and ligated into pGEM-7Z (f)ϩ cloning vector (Promega). The DNA sequences of this and other cloned inserts used in this study were verified.
Construction of protein expression plasmids. A codon-optimized version of CT406 from Chlamydia trachomatis serovar D was generated (Verdezyne, Carls- and myc tags. Overexpression and purification of CT406. An overnight culture of pMT1565 transformed into E. coli TOP10 (Invitrogen) was diluted 1:100 in LB broth containing 100 mg/ml ampicillin. After growth at 37°C to an optical density at 600 nm (OD 600 ) of ϳ0.5, CT406 expression was induced with 0.002% (wt/vol) Larabinose followed by overnight incubation at 16°C. Cells were harvested by centrifugation at 2,000 ϫ g for 10 min at 4°C, and the cell pellet was stored at Ϫ80°C. To purify recombinant CT406 protein, thawed cells were resuspended in protein purification buffer (20 mM ethanolamine [pH 10], 300 mM NaCl, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml pepstatin A, and 100 g/ml lysozyme) and disrupted by sonication. The lysate was cleared by centrifugation at 20,000 ϫ g for 30 min at 4°C and incubated with a 1-ml bed volume of equilibrated Talon metal affinity resin (Clontech) at 4°C for 1 h with agitation. The resin was collected by centrifugation and washed 3 times with 20 volumes of protein purification buffer at 4°C for 20 min with agitation. Protein was eluted with 5 volumes of protein purification buffer containing 50 mM imidazole. The eluate was pooled and concentrated to 1 ml using a Vivaspin 6 column (GE Healthcare) and then dialyzed against protein storage buffer. For protein stocks used in electrophoretic mobility shift assay (EMSA) experiments, storage buffer contained 20 mM ethanolamine (pH 10), 10 mM MgCl 2 , 10 mM 2-mercaptoethanol, 100 mM NaCl, and 30% (wt/vol) glycerol. For in vitro transcription experiments, a low-salt storage buffer was used (10 mM Tris [pH 8], 10 mM MgCl 2 , 10 mM 2-mercaptoethanol, and 30% [wt/vol] glycerol). Aliquots of rCT406 were stored at Ϫ80°C. Protein concentration was determined using the Bio-Rad protein assay.
Production of polyclonal antibodies. Recombinant CT406 was gel purified by SDS-PAGE and used to generate rabbit polyclonal antibodies (Harlan Bioproducts for Science). Antibodies were then affinity purified using a protein A-agarose column according to the manufacturer's instructions (Bio-Rad).
Construction and labeling of gel shift assay probes. The following DNA probes were generated by annealing cDNA oligonucleotides: the nrdAB promoter region with predicted tandem NrdR boxes from C. trachomatis serovar D (T1137 and T1138); the nrdAB upstream NrdR box only (T1689 and T1690); the nrdAB downstream NrdR box only (T1693 and T1694); and a nonspecific oligonucleotide probe containing sequences upstream of the C. trachomatis ytg operon (T1326 and T1327). Each annealed oligonucleotide probe contained a 5Ј EcoRI overhang and a 3Ј BamHI overhang for fill-in labeling with [␥- 32 P]dATP as previously described (43) .
DNA gel shift assay. Electrophoretic mobility shift assay (EMSA) reactions were performed by incubating a range of concentrations of recombinant CT406 with 0. [wt/vol] glycerol). Some reactions also contained anti-myc antibodies. Reaction mixtures were incubated at room temperature for 30 min and then loaded onto a 6% polyacrylamide gel and electrophoresed at 150 V at 4°C in 0.5ϫ Tris-borate buffer. Following electrophoresis, gels were dried, exposed to a phosphorimager plate, and visualized as previously described (43) .
Generation of E. coli nrdR null mutant. A strain of E. coli lacking the nrdR gene was generated using the method of Datsenko and Wanner (6) . The entire nrdR locus was deleted from the region immediately downstream of the transcription start site to its stop codon. Primers T1350b and T1351, which contain homologous sequences that flank the nrdR gene locus and leave the nrdR promoter intact, were used to amplify the kanamycin resistance cassette from pKD4 (6) . The PCR product was purified by agarose gel electrophoresis with the QIAquick gel extraction kit (Qiagen) and electroporated into E. coli BW25113/ pKD46 (6) . Following selection for kanamycin resistance, homologous recombination of the Kan r cassette was verified by PCR. The kanamycin resistance marker was then transduced into E. coli K-12-MG1655 by P1vir (37) . Transductants were selected on LB medium containing kanamycin and verified by colony PCR. A positive transductant was then electroporated with pCP20 for removal of the kanamycin resistance gene by FLP recombinase (6) to generate E. coli K-12-MG1655⌬nrdR. Removal of Kan r was confirmed by PCR and sequencing of the target locus, which matched the pKD4 FLP scar sequence described previously (6) . We verified that the loss of nrdR did not produce a significant phenotype during normal growth, which is in agreement with published studies (3, 41) , and we confirmed that transcription of the downstream gene ribD was unaffected by reverse transcription (RT)-PCR (data not shown). Strains and plasmids used in this study are shown in Table 2 .
Construction of luciferase reporter plasmids. The luciferase reporter vector pMT1580 was constructed by cloning the luxAB genes from Vibrio harveyi into the pACYC177 cloning vector (ATCC). First, the luxA gene was amplified by PCR using Pfu DNA polymerase with primers T1490 and T1513 from the pQF110 template (25) . The insert was ligated into pACYC177 at a blunted BamHI site. Clones were selected on LB medium containing ampicillin, and the correct insert was verified by PCR. This luxA plasmid was purified from E. coli XL1-Blue by using the Nucleobond AX kit (Macherey-Nagel) according to the manufacturer's instructions.
The luxB gene was also amplified by PCR using primers T1491 and T1512 from pQF110. This insert was digested with EcoRI at its 5Ј end and ligated into EcoRI and blunted AatII sites of the luxA plasmid. After verifying the DNA sequence of luxAB, the ampicillin resistance cassette on the vector backbone was disrupted by digestion with ApaLI and AhdI, followed by blunting and religation to produce pMT1580. The disruption of Amp r was confirmed by lack of growth on LB medium containing ampicillin.
The following reporter plasmids were constructed from PCR-amplified promoter inserts digested with KpnI and cloned upstream of luxAB at KpnI and blunted XbaI sites in pMT1580: pMT1581 containing the nrdH promoter amplified with T1521 and T1522 from E. coli K-12-MG1655 genomic DNA; pMT1582 containing the nrdAB promoter region amplified with T1523 and T1524 from C. trachomatis serovar D genomic DNA (7). The pMT1616 reporter containing the C. trachomatis ytg operon promoter region was constructed by annealing complementary oligonucleotides T1599 and T1600 and ligated between blunted XbaI sites in pMT1580.
Luciferase reporter assays. Each luciferase reporter construct was cotransformed with either empty pBAD-ITO vector, pMT1565, or pMT1566 into E. coli K-12-MG1655⌬nrdR and selected on LB medium containing ampicillin and kanamycin. An overnight culture was diluted 1:100 in LB medium containing ampicillin, kanamycin, and 0.2% L-arabinose and incubated at 37°C. Hydroxyurea (15 mM or 100 mM) was added to some cultures once an OD 600 of ϳ0.2 was reached. After growth to an OD 600 of ϳ0.8, a sample of the culture was diluted to an OD 600 of 0.1 in culture medium. Twenty-five microliters of the diluted sample was added to 75 l of luciferase reaction buffer (50 mM sodium phosphate buffer [pH 7], 50 mM 2-mercaptoethanol, 2% [wt/vol] bovine serum albumin [BSA] , and n-decanal [1:2,000 final dilution]). The reactions were incubated at room temperature for 10 min in the dark, and then light production was measured over 10 s on a Sirius luminometer V3.1 (Berthold Detection Systems) and reported as relative light units (RLU) per second. All measurements were performed in triplicate, and the data presented are the means of three independent experiments. Statistical analysis of the results by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test was performed using GraphPad Prism v5.0 software. Expression of pMT1565 and pMT1566 was confirmed by SDS-PAGE and Western blot analysis.
Construction of in vitro transcription templates. Two synthetic promoters were generated by addition of an NrdR box to the C. muridarum (also known as C. trachomatis MoPn) dnaK promoter. The insert for pMT1587 (NrdR boxes from C. trachomatis serovar D nrdAB) was generated by annealing singlestranded oligonucleotides T1527 and T1528, followed by digestion with EcoRI (Promega) and phosphorylation with T4 polynucleotide kinase (New England BioLabs). Similarly, the insert for pMT1608 (NrdR boxes from E. coli nrdH) was generated by annealing oligonucleotides T1575 and T1576. The inserts were ligated into pMT1125 digested with EcoRI and EcoRV (43) . Construction of the wild-type dnaK promoter template (pMT1161) was described previously (30) .
Purification of chlamydial RNA polymerase. RNA polymerase holoenzyme was biochemically purified from C. trachomatis serovar L2 reticulate bodies at 21 h postinfection as previously described (36) .
In vitro transcription assay. Transcription of chlamydial promoter templates was performed as described previously (36) , with several modifications. DNA template (1 l [5 nM]) was incubated in the presence of varying concentrations of purified recombinant CT406 protein at room temperature for 15 min in 9 l of protein storage buffer. Following preincubation of protein and the DNA template, the transcription reaction mixture (1 l rRNAsin [Promega], 0.5 l chlamydial RNA polymerase, 400 M ATP, 400 M UTP, 100 M mGTP, and 0.8 l [ at 65°C. The transcripts were resolved by electrophoresis with visualization and quantification as previously described (43) .
RESULTS
The nrdAB promoter overlaps predicted NrdR boxes. To study the regulation of the ribonucleotide reductase genes in Chlamydia, we first identified the promoter of the nrdAB operon. We mapped the transcription start site for C. trachomatis nrdAB by using 5Ј RACE and predicted a candidate promoter immediately upstream (Fig. 1A) that has sequence similarity to the preferred C. trachomatis 66 promoter (29, 34, 36) . Using an in vitro transcription assay, we verified that this promoter is transcribed by chlamydial 66 RNA polymerase (data not shown). Intriguingly, the nrdAB promoter is in the immediate vicinity of tandem NrdR boxes that are conserved in all Chlamydia spp. (24) . The upstream NrdR box overlaps the Ϫ10 promoter element that we predicted, and the second NrdR box is located just downstream of the transcription start site (Fig. 1A) . This overlapping arrangement of the promoter and NrdR boxes is conserved among Chlamydia spp. (Fig. 1A) and is similar to the E. coli nrdAB promoter (Fig. 1B) (41) . The close proximity of the tandem NrdR boxes and the nrdAB promoter supports a model for the repression of the nucleotide reductase genes in Chlamydia by an NrdR ortholog.
CT406 binds upstream of nrdAB.
To test whether CT406 is the chlamydial NrdR ortholog, we first examined whether it can bind the NrdR boxes of the nrdAB operon. In an electrophoretic mobility shift assay (EMSA), myc-tagged recombinant CT406 produced a concentration-dependent gel shift with a 78-bp oligonucleotide DNA probe containing the tandem NrdR boxes in their native location relative to the nrdAB promoter ( Fig. 2A) . We detected at least three shifted bands, indicating the formation of multiple higher-order rCT406-DNA complexes, which have been described for NrdR orthologs in E. coli and S. coelicolor (10, 11, 41) . Binding was sequence specific, since rCT406 did not produce a gel shift with a probe containing the C. trachomatis ytg promoter, which does not contain a recognizable NrdR box (Fig. 2B) . We verified that the observed gel shift is due to rCT406 by showing that antibodies to the myc tag disrupted the gel shift in a concentration-dependent manner (Fig. 2C) .
To examine whether both NrdR boxes are necessary for rCT406 binding, we repeated the EMSA studies with DNA probes in which either box was disrupted by sequence substitutions at the most conserved positions within the chlamydial NrdR boxes (Fig. 3A) (24) . We observed no gel shift when we tested mutant nrdAB DNA probes containing only an intact downstream or upstream NrdR box (Fig. 3B) . These results indicate that the tandem NrdR boxes are necessary for binding of CT406 to the C. trachomatis nrdAB promoter and together make up the functional operator.
CT406 represses transcription in vitro. We used a chlamydial in vitro transcription assay to test if rCT406 is a functional repressor. Our assay utilizes a G-less cassette transcription template, which allows transcription of a specific promoter in the absence of GTP to limit background transcription initiated elsewhere on the plasmid template (35) . However, we could not test the native C. trachomatis nrdAB promoter under these conditions because the NrdR box downstream of the transcription start site encodes G residues (Fig. 1A) . We were also unable to test the native nrdAB promoter with a run-off transcription assay because the nrdAB promoter was only weakly transcribed from a linear template (data not shown). As a solution, we tested NrdR boxes in the context of a well-defined chlamydial promoter. We placed tandem NrdR boxes upstream and downstream of the Ϫ35 element of the dnaK promoter to preserve the spacing between the two boxes without altering the promoter sequence (Fig. 4A) . rCT406 caused a concentration-dependent decrease in transcription of a dnaK promoter containing tandem NrdR boxes from either E. coli nrdH or C. trachomatis nrdAB (Fig. 4B) . At the highest concentration of rCT406 tested, there was 96% repression with the nrdH NrdR boxes and 85% repression with the nrdAB NrdR boxes (Fig. 4B) . In contrast, rCT406 did not cause a significant change in transcription from the wild-type dnaK promoter (Fig. 4B) . These results indicate that CT406 can function as a transcriptional repressor and that its activity is dependent on the presence of the NrdR boxes in the vicinity of the target promoter.
CT406 represses transcription in vivo. Since there is no experimental genetic system for Chlamydia, we used a luciferase reporter assay in E. coli to validate these in vitro results and to test for repression of the native chlamydial nrdAB promoter. We constructed reporter plasmids by cloning the promoter sequences of E. coli nrdH, C. trachomatis nrdAB, or the C. trachomatis ytg operon upstream of Vibrio harveyi luxAB (25) . To avoid confounding effects from endogenous E. coli NrdR, we performed these experiments in a strain in which we had deleted the nrdR locus. Expression of recombinant CT406 reduced the activity of the nrdH reporter by approximately 70% (Fig. 5 ). We measured a similar level of repression when we expressed E. coli NrdR from a plasmid in this nrdR deletion strain. We observed more modest repression of the nrdAB reporter with expression of either CT406 or E. coli NrdR, although the effect was statistically significant. This differential regulation of promoters is consistent with studies in E. coli in which NrdR caused less repression of the nrdAB promoter compared to the nrdH promoter (41) . In a control experiment, neither CT406 nor E. coli NrdR repressed expression from the control ytg reporter, which does not contain a predicted NrdR box. These results provide additional experimental support for CT406 as a transcriptional repressor of ribonucleotide reductase genes. CT406-and E. coli NrdR-mediated repression is reversed by hydroxyurea treatment. To examine whether NrdR-mediated repression is regulated by a nucleotide cofactor, we treated the E. coli ⌬nrdR strain used in the reporter assay with hydroxyurea to inhibit ribonucleotide reductase and lower intracellular dNTP levels (31) . When the NrdR deletion strain expressed CT406 from a plasmid, repression of the E. coli nrdH reporter was partially reversed by treatment with 15 mM hydroxyurea and completely reversed at 100 mM hydroxyurea (Fig. 6) . We observed similar results with control experiments in which the ⌬nrdR strain was complemented with E. coli NrdR. For these experiments, we verified that expression levels of CT406 and E. coli NrdR were adequate by Western blot (data not shown). This hydroxyurea-mediated derepression was specific for promoters regulated by CT406 and NrdR, since we observed no effect on ytg reporter activity at either hydroxyurea concentration. These data indicate that repression by NrdR and CT406 is sensitive to hydroxyurea, which is consistent with recent findings in Salmonella (21) . Since hydroxyurea reduces deoxyribonucleotide levels by inhibiting the conversion of NDPs to dNDPs (31), our results support a model in which transcriptional repression by CT406 and E. coli NrdR is modulated by deoxyribonucleotides.
DISCUSSION
In this study, we provide direct functional evidence that E. coli NrdR is a transcriptional repressor and that CT406 is the ortholog of NrdR in Chlamydia. We showed that rCT406 binds upstream of the nrdAB operon, which encodes the only copy of ribonucleotide reductase in the genomes of C. trachomatis and other Chlamydia spp. (26, 33) . Our data suggest that the tandem NrdR boxes upstream of C. trachomatis nrdAB make up the functional operator since rCT406 required both boxes for binding in vitro. This result differs from what is seen for E. coli, in which only the downstream NrdR box of nrdAB was necessary for binding by NrdR (41) . In an in vitro transcription assay, rCT406 repressed transcription in a manner that was dependent on the NrdR boxes. We validated these results with an in vivo luciferase reporter assay in which both CT406 and E. coli NrdR repressed the E. coli nrdH promoter, and to a lesser extent the C. trachomatis nrdAB promoter. We also showed that NrdR-dependent repression of nrdH was reversed by hydroxyurea treatment, suggesting that NrdR and CT406 regulate transcription in response to intracellular nucleotide levels.
The modest repression of the C. trachomatis nrdAB promoter by CT406 and E. coli NrdR is consistent with prior studies that showed that NrdR does not repress all its target promoters to the same degree (10, 41) . These promoter-specific effects have been proposed to be due to either the location of the operator relative to the promoter or the operator sequence (41). While we found that there was less repression from the C. trachomatis nrdAB promoter than the E. coli nrdH promoter, the NrdR boxes of either promoter were sufficient to produce a high level of repression by CT406 in the context of the dnaK promoter (Fig. 4B) . This result indicates that the difference in the two operators is not due to the operator se- There has been speculation that the activity of NrdR is regulated by a nucleotide cofactor. There are many examples where the activity of a transcription factor that controls the expression of a metabolic enzyme is regulated by a cofactor. For instance, the chlamydial aporepressor TrpR requires tryptophan as a corepressor in order to bind its cognate operator and repress transcription of the tryptophan biosynthetic genes (1, 4) . While both E. coli NrdR and CT406 have the potential to bind ATP and dATP via the conserved ATP cone domain (10, 11) , a role for a nucleotide cofactor has not been demonstrated with functional evidence. For example, the addition of nucleotide triphosphates (NTPs) or dNTPs did not affect the binding of E. coli NrdR to its operator in EMSA experiments (41) . In our in vitro studies, CT406 operator binding was similarly insensitive to NTPs and dNTPs (data not shown), and CT406 was sufficient to repress transcription in vitro without the addition of exogenous dNTPs. Recombinant NrdR purified from bacteria, however, has been shown to contain ATP and dATP (10, 41) , which may explain why a nucleotide cofactor requirement has not been demonstrated with in vitro studies. We were unable to directly assess whether our CT406 preparation contains bound nucleotides because we were unable to purify large enough quantities of this recombinant protein.
Our in vivo finding that hydroxyurea treatment reversed repression by both E. coli NrdR and CT406 provides evidence that the activities of these repressors can be modulated by intracellular nucleotide levels. Hydroxyurea decreases intracellular dNTP pools by inhibiting the activity of class I ribonucleotide reductases (31) . We propose that deoxyribonucleotide is required as a corepressor for NrdR-mediated repression and that its depletion by hydroxyurea treatment caused the observed derepression. In contrast, it is unlikely that ribonucleotide acts as an inducer of ribonucleotide reductase genes, because CT406 was able to repress even when a molar excess of ribonucleotides was present for the transcription reaction (Fig. 4B) . A deoxyribonucleotide corepressor would allow NrdR to sense high intracellular dNTP levels and respond by repressing ribonucleotide reductase expression. This corepressor model would also provide a mechanism to explain the observation that hydroxyurea treatment induces the transcriptional expression of ribonucleotide reductase (8, 15, 16, 32, 42) .
Work with other bacteria has shown that the ribonucleotide reductase genes can be transcriptionally regulated by additional factors, but we do not know if these mechanisms are operative in Chlamydia. In E. coli, nrdAB transcription is also controlled by DnaA, Fis, and IciA (9, 12, 14) . Chlamydia does not encode obvious orthologs of Fis and IciA, but two DnaA genes have been predicted in the C. trachomatis genome (33) . DnaA is best known as a DNA replication initiation factor, but when it is bound to ATP, it represses the transcription of nrdAB in E. coli by binding to an upstream operator (9, 20) . Interestingly, we have identified an A/T-rich sequence immediately upstream of the C. trachomatis nrdAB Ϫ35 element (Fig. 1A) , which resembles a DnaA box for binding by DnaA (28) .
In summary, this study provides evidence that CT406 is an ortholog of NrdR and that its regulatory target is the nrdAB ribonucleotide reductase operon. CT406 is likely to be a key regulator in Chlamydia, since ribonucleotide reductase is the only means that chlamydiae have to produce deoxyribonucleotides by conversion from imported ribonucleotides (38) . Furthermore, by regulating this critical conversion step, chlamydial NrdR has the potential to control the balance between ribonucleotides for transcription and energy production, and deoxyribonucleotides for DNA replication.
